|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09887 LEADS BIOLABS-B
Nominal 
88.000 +14.000 (+18.919%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Investment Properties | -- | -- | 0 | 0 |
| Property, plant, equip. & others | -- | -- | 36,378 | 54,282 |
| Land & other Lease Assets | -- | -- | 11,189 | 6,812 |
| Intangible Assets | -- | -- | 0 | 0 |
| Interests in Asso. & JCEs | -- | -- | 0 | 0 |
| Other Non-current Assets | -- | -- | 25,569 | 19,267 |
| -- | -- | 73,136 | 80,361 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||
| Inventories | -- | -- | 0 | 0 | |
| Trade Receivables | -- | -- | 0 | 0 | |
| Cash & Bank Balances | -- | -- | 372,542 | 247,523 | |
| Other Current Assets | -- | -- | 223,765 | 119,598 | |
| Assets Held for Sale | -- | -- | 0 | 0 | |
| -- | -- | 596,307 | 367,121 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |||
| Trade Payables | -- | -- | 3,524 | 215 | ||
| S-T Debt & Leases | -- | -- | 260,928 | 65,311 | ||
| Other Current Liabilities | -- | -- | 133,884 | 1,328,984 | ||
| Liab asso w/ Assets Held for Sale | -- | -- | 0 | 0 | ||
| -- | -- | 398,336 | 1,394,510 | |||
| Net Current Assets | -- | -- | 197,971 | (1,027,389) | ||
| Total Assets Less Current Liabilities | -- | -- | 271,107 | (947,028) | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||||
| L-T Debt & Leases | -- | -- | 5,547 | 1,777 | |||
| Other Non-current Liabilities | -- | -- | 0 | 0 | |||
| -- | -- | 5,547 | 1,777 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |||||
| Share Capital | -- | -- | 156,500 | 17,018 | ||||
| Reserves | -- | -- | 109,060 | (965,823) | ||||
| Others | -- | -- | 0 | 0 | ||||
| Shareholders' Funds | -- | -- | 265,560 | (948,805) | ||||
| Non-controlling Interests | -- | -- | 0 | 0 | ||||
| Others | -- | -- | 0 | 0 | ||||
| -- | -- | 265,560 | (948,805) | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Commitments | -- | -- | 143 | 1,057 |
| Contingent Liabilities | -- | -- | 0 | 0 |
| Remarks: | Real time quote last updated: 01/04/2026 17:23 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -211,419 |
| %Change | -29.811% |
| EPS / (LPS) | RMB -1.210 |
| NBV Per Share (¥) | RMB -- |